Cramer's lightning round: If you want to invest in non-opioid painkillers, buy Canopy Growth

Jim Cramer flies through his take on callers' favorite stocks, including that of a biotechnology company developing non-opioid pain medication.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.